Publications
Where expertise meets impact
Berry doesn’t just follow industry standards — we set them. Our team of award-winning statisticians, journal editors, and regulatory advisors leads the field in Bayesian and adaptive trial design. With research published in The New England Journal of Medicine, JAMA, and The Lancet, we’re driving innovation where it matters most.
Over 90% of our scientists published influential work this past year, advancing adaptive, Bayesian, and platform trial methodology. Our blend of academic rigor, regulatory insight, and real-world experience makes Berry a true authority in modern clinical trials.
Explore our most impactful peer-reviewed publications below.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Journal of the American Statistical Association
Methodology
Survival analysis
Addressing Multiple Detection Limits with Semiparametric Cumulative Probability Models
April 1, 2024
2024
DOI: 10.1080/01621459.2024.2315667
Clinical Pharmacology & Therapeutics (CPT)
Methodology
Platform
Regulatory Issues of Platform Trials: Learnings from EU-PEARL
March 26, 2024
2024
doi: 10.1002/cpt.3244
Project Euclid
Methodology
Survival analysis
Bayesian Nonparametric Bivariate Survival Regression for Current Status Data
March 1, 2024
2024
Statistics in Biopharmaceutical Research
Methodology
Allocation
Effects of Allocation Method and Time Trends on Identification of the Best Arm in Multi-Arm Trials
January 2, 2024
2024
DOI:10.1080/19466315.2023.2298961
BMJ Open
Surgery
Platform
REMAP Periop: a randomised, embedded, multifactorial adaptive platform trial protocol for perioperative medicine to determine the optimal enhanced recovery pathway components in complex abdominal surgery patients within a US healthcare system
December 28, 2023
2023
doi:10.1001/jama.2023.3651
Society for Clinical Trials
Blood
Dose Ranging
Design and logistical considerations for the randomized adaptive non-inferiority storage-duration-ranging CHIlled Platelet Study
December 21, 2023
2023
doi.org/10.1177/1740774522112642
The New England Journal of Medicine
Infectious Disease
COVID-19
Platform
Simvastatin in Critically Ill Patients with Covid-19
December 21, 2023
2023
doi: 10.1056/NEJMoa2309995.
JAMA
Infectious Disease
COVID-19
Platform
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
December 16, 2023
2023
doi:10.1001/jama.2022.23257
No results found.
There are no results with this criteria. Try changing your search.